A PILOT TRIAL of a DISPOSABLE INTRACEREBRAL ASPIRATION ENDOSCOPE for the TREATMENT of INTRACEREBRAL HEMATOMA(FAST-HET)
Key facts
- Who runs it
- MicroPort NeuroTech Co., Ltd.
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 16 people, planned
- Started
- 6 Feb 2025
- Planned end
- 31 Oct 2025
- Type of study
- Interventional
- Treatments tested
- Endoscopic surgery
- Record updated
- 25 February 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (23)Hide the full registry criteria
Who can take part
- Age ≥ 18 and ≤ 80 years old
- Spontaneous intracerebral hemorrhage
- Hemorrhage located in the supratentorial subcortical or basal ganglia region
- Hematoma volume ≥ 30ml and ≤ 80ml
- Able to undergo surgery within 72 hours after onset
- GCS score of 5 to 14
- The subject themselves and/or their authorized representative can understand the purpose of the study, agree to participate, and sign the informed consent form
Who cannot take part
- Use of anticoagulants or antiplatelet drugs within 14 days before onset, or the need for long-term use of anticoagulants or antiplatelet drugs, or other factors causing coagulation dysfunction
- Currently participating in any drug or device research, or planning to participate in other drug or device clinical trials
- History of intracerebral hemorrhage within the past year
- Traumatic intracerebral hemorrhage
- Multiple intracerebral hemorrhages; Note: Hemorrhage in the supratentorial subcortical or basal ganglia region that extends into the ventricles is not considered multiple hemorrhages and can be included
- Known or suspected intracerebral hemorrhage caused by tumors, aneurysms, vascular malformations, hemorrhagic transformation of ischemic stroke, cerebral venous thrombosis, etc
- Severe neurological or psychiatric disorders before onset (such as epilepsy, Alzheimer's disease, Parkinson's disease, schizophrenia, depression, etc.)
- Active bleeding present, such as gastrointestinal bleeding, respiratory bleeding, or subcutaneous hematoma
- Uncontrolled hypertension that cannot be managed with medication (systolic blood pressure > 220 mmHg or diastolic blood pressure > 120 mmHg after medication upon admission)
- Severe systemic diseases that cannot tolerate surgery, such as severe liver or kidney dysfunction
- Platelet count less than 100 × 10\^3/μL or international normalized ratio (INR) greater than 1.4
- Women of childbearing age who are pregnant or breastfeeding
- Formation of brain herniation
- mRS score ≥ 3 before onset
- Life expectancy ≤ 1 year
- Other situations where the researcher deems the subject unsuitable for the study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Intracerebral hemorrhage
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This clinical trial is a prospective, open-label, single-arm clinical trial. According to the inclusion and exclusion criteria specified in the trial protocol, no fewer than 16 subjects with cerebral hemorrhage will be enrolled in 1 to 2 clinical centers. Considering the learning period required for doctor to become proficient in using the device, the first three cases at each research center are considered as the lead-in period cases and will not be included in the primary analysis dataset. During the surgery, a disposable intracerebral aspiration endoscope will be used to remove the intracerebral hematoma. Follow-ups will be conducted at discharge/Day 7 (±1 day), postoperative 1 month (±7 days), and postoperative 3 months (±15 days). Recording various indicators to evaluate the safety and effectiveness of the disposable intracerebral aspiration endoscope in treating intracerebral hematoma.
The group in the trial
- Endoscopic surgeryTreatment being tested
Using a disposable intracerebral aspiration endoscope to remove the intracerebral hematoma
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06843616, who can take part
- Record updated
- 25 February 2025